OPEN APP
Home >Companies >News >Dr Reddy's to sell Neurology branded products to Usher-Smith
 (Photo: Pradeep Gaur/Mint)
(Photo: Pradeep Gaur/Mint)

Dr Reddy's to sell Neurology branded products to Usher-Smith

  • The closing of the transaction is subject to various customary closing conditions
  • Shares of Dr Reddy's Lab traded at 2529.65 on BSE, down 2.18% in the morning

Mumbai: Dr Reddy's Laboratories Ltd on Friday said it has signed a definitive pact with Upsher-Smith Laboratories, LLC to sell its neurology branded products.

Under the agreement, Dr Reddy's will receive $70 million as upfront consideration, $40.50 million in near-term milestones and additional financial considerations including, existing contractual obligation and inventory. It will also get sales-based royalties on a quarterly basis.

"Dr. Reddy's would sell its US and select territory rights for ZEMBRACE® SYMTOUCH® (sumatriptan injection) 3 mg and TOSYMRA™ (sumatriptan nasal spray) 10 mg, (formerly referred to as "DFN-02"), which are commercialized through its wholly owned subsidiary, Promius Pharma, LLC", the company said in a BSE filing.

The closing of the transaction is subject to various customary closing conditions including antitrust review under Hart-Scott-Rodino Act, according to the exchange notification.

At 11.22 am, shares of Dr Reddy's Lab traded at 2529.65 on BSE, down 2.18% from previous close, while India's benchmark equity index Sensex was down 0.48% at 39,559.98.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Close
×
My Reads Redeem a Gift Card Logout